TIDMD467 
 
   Downing FOUR VCT plc (the "Company") 
 
   LEI: 21380035MV1VRYEXPR95 
 
   3 June 2021 
 
   Portfolio Update 
 
   The Directors of the Company are pleased to report that Generalist and 
Healthcare Share portfolio company, Arecor Therapeutics ("Arecor"), has 
today had its ordinary shares admitted to trading on AIM. The admission 
follows a successful GBP20.0 million placing of new shares at a price of 
226 pence per ordinary share (the "placing price"). 
 
   Based on the placing price, the values of the Company's Generalist and 
Healthcare Share pools' holdings in Arecor have increased by 
approximately 0.9p per Generalist Share and 8.0p per Healthcare Share. 
This is equivalent to increases of 1.3% and 11.4% in the unaudited NAVs 
of the Generalist and Healthcare Share pools respectively, as at 28 
February 2021 (being the most recent NAVs announced by the Company). 
 
   Enquiries: 
 
   Grant Whitehouse 
 
   Downing LLP 
 
   Company Secretary 
 
   020 7630 4333 
 
 
 
 

(END) Dow Jones Newswires

June 03, 2021 10:42 ET (14:42 GMT)

Copyright (c) 2021 Dow Jones & Company, Inc.
Thames Ventures Vct 2 (LSE:D467)
Gráfica de Acción Histórica
De Feb 2024 a Mar 2024 Haga Click aquí para más Gráficas Thames Ventures Vct 2.
Thames Ventures Vct 2 (LSE:D467)
Gráfica de Acción Histórica
De Mar 2023 a Mar 2024 Haga Click aquí para más Gráficas Thames Ventures Vct 2.